ANNX.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (16 Apr 2024 @ 11:04):

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. The company develops ANXV, a human recombinant protein...

Stats
Today's Volume	405 950
Average Volume	369 625
Market Cap	96.70M
EPS	SEK-0.0700 ( 2023-09-30 )
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-1.070
ATR14	SEK0.00400 (1.43%)

Annexin Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Annexin Pharmaceuticals Financials

Annual	2023
Revenue:	SEK0
Gross Profit:	SEK-193 000 (0.00 %)
EPS:	SEK-0.260

Q4	2023
Revenue:	SEK0
Gross Profit:	SEK-48 000.00 (0.00 %)
EPS:	SEK-0.0420

Q3	2023
Revenue:	SEK0
Gross Profit:	SEK-48 000.00 (0.00 %)
EPS:	SEK-0.0406

Q2	2023
Revenue:	SEK0
Gross Profit:	SEK-48 000.00 (0.00 %)
EPS:	SEK-0.0321

Financial Reports:

No articles found.

Annexin Pharmaceuticals

Annexin Pharmaceuticals AB (publ), a biotechnology company, develops drug candidates for the treatment of various cardiovascular diseases. The company develops ANXV, a human recombinant protein. It offers Annexin A5 to protect and repair blood vessels and counteract inflammation. The company was founded in 2014 and is based in Stockholm, Sweden.